Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Batch and lot number: The COA must match the lot number on the vial you received
Proper dosing, slow infusion, and clinical monitoring help minimize risk
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Serious Side Effects : Rarely, allergic reactions can occur
PubMed laboratory research record [PMID: 9736316] PubMed record related to this compound for laboratory literature review
For patients asking about skin texture, firmness, fine lines, or scalp support, topical GHK-Cu is the route we are comfortable discussing in a medical aesthetics setting
